Is Menactra a MCV?
Is Menactra a MCV?
One type of MCV4, Menveo, is licensed for use in people ages 2 to 55. Another version, Menactra, is approved for those 9 months to 55 years old. MPSV4 is the only vaccine licensed for use in people over 55 as well as people 2 to 55. Both vaccines protect against four types of meningococcal disease.
What is Menactra immunization?
Menactra (meningococcal conjugate vaccine) is used to prevent infection caused by serogroups A, C, W, and Y. This vaccine helps your body develop immunity to meningitis.
What is on a vis sheet?
Vaccine Information Statements (VISs) are information sheets produced by the CDC that explain both the benefits and risks of a vaccine to vaccine recipients. Federal law requires that healthcare staff provide a VIS to a patient, parent, or legal representative before each dose of certain vaccines.
What ingredients are in Menactra?
What Menactra vaccine contains. The active substance is 4 µg of each polysaccharide per serogroup A, C, Y and W-135 conjugated to approximately 48 µg diphtheria toxoid. The other ingredients are excipients: sodium chloride, sodium phosphate – dibasic anhydrous and sodium phosphate – monobasic.
How many years does Menactra last?
What meningococcal vaccines are available in the United States?
Trade Name | Type of Vaccine | Approved Ages |
---|---|---|
Menactra | Conjugate | 9 mos.–55 years* |
Menveo | Conjugate | 2 mos.–55 years* |
MenQuadfi | Conjugate | 2 years and older |
Trumenba | Protein | 10–25 years* |
How often do you need Menactra?
Administer MenACWY vaccines (Menactra® or Menveo®) to adolescents as 1 primary dose at 11 to 12 years of age. Administer 1 booster dose at 16 years of age. The minimum interval between doses is at least 8 weeks.
Is Menactra the meningitis vaccine?
Vaccines can help prevent meningococcal disease, which is any type of illness caused by Neisseria meningitidis bacteria. There are 2 types of meningococcal vaccines available in the United States: Meningococcal conjugate or MenACWY vaccines (Menactra® and Menveo®)
What are the benefits of using the IIS for providers?
IIS CAPTURE THE VACCINATION STATUS OF THE POPULATION immunization records, and helps keep track of a patient’s immunization status. practice. Provides patients with official copies of immunization records. Tracks administered vaccines to ensure proper reimbursement.
Where can you find your immunization records?
The Centers for Disease Control and Prevention (CDC) has a listing of registry contacts and websites at www.cdc.gov/vaccines/programs/iis/contacts-locate- records. html. Or to find the phone number of your local health depart ment, call the CDC Information Contact Center at 800-CDC-INFO (232-4636).
When do you give Menactra?
Administer MenACWY vaccines (Menactra® or Menveo®) to adolescents as 1 primary dose at 11 to 12 years of age. Administer 1 booster dose at 16 years of age.
At what age is Menactra given?
Who needs Menactra?
Menactra (MenACWY-D) can be given to children 9 months and older at increased risk of meningococcal disease. MenQuadfi (MenACWY-TT) may be used for children at increased risk who are age 2 years and older.